Ontrak (OTRK) Competitors $0.02 -0.02 (-50.00%) As of 09/5/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OTRK vs. BACK, BTTX, UPHL, OPGN, ACONW, AONC, DHACW, FMS, LFMDP, and OTRKPShould you be buying Ontrak stock or one of its competitors? The main competitors of Ontrak include IMAC (BACK), Better Therapeutics (BTTX), UpHealth (UPHL), OpGen (OPGN), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), and Ontrak (OTRKP). These companies are all part of the "healthcare" industry. Ontrak vs. Its Competitors IMAC Better Therapeutics UpHealth OpGen Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak Ontrak (NASDAQ:OTRK) and IMAC (NASDAQ:BACK) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk. Does the media favor OTRK or BACK? In the previous week, Ontrak and Ontrak both had 1 articles in the media. Ontrak's average media sentiment score of 0.00 beat IMAC's score of -1.11 indicating that Ontrak is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ontrak 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral IMAC 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative Which has better earnings and valuation, OTRK or BACK? IMAC has lower revenue, but higher earnings than Ontrak. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOntrak$10.18M0.01-$25.49M-$15.810.00IMAC$72.05K2.07-$9.42MN/AN/A Do insiders and institutionals believe in OTRK or BACK? 12.9% of Ontrak shares are held by institutional investors. Comparatively, 5.8% of IMAC shares are held by institutional investors. 1.9% of Ontrak shares are held by insiders. Comparatively, 12.3% of IMAC shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend OTRK or BACK? Ontrak presently has a consensus price target of $3.00, indicating a potential upside of 14,900.00%. Given Ontrak's stronger consensus rating and higher possible upside, equities analysts plainly believe Ontrak is more favorable than IMAC.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ontrak 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00IMAC 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is OTRK or BACK more profitable? IMAC has a net margin of 0.00% compared to Ontrak's net margin of -274.20%. IMAC's return on equity of 0.00% beat Ontrak's return on equity.Company Net Margins Return on Equity Return on Assets Ontrak-274.20% -269.88% -128.35% IMAC N/A N/A -325.44% Which has more risk and volatility, OTRK or BACK? Ontrak has a beta of 1.97, indicating that its share price is 97% more volatile than the S&P 500. Comparatively, IMAC has a beta of 2.36, indicating that its share price is 136% more volatile than the S&P 500. SummaryOntrak beats IMAC on 7 of the 13 factors compared between the two stocks. Get Ontrak News Delivered to You Automatically Sign up to receive the latest news and ratings for OTRK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OTRK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OTRK vs. The Competition Export to ExcelMetricOntrakMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$84K$4.16B$5.79B$9.94BDividend YieldN/A1.24%6.70%4.53%P/E Ratio0.0029.0176.3726.13Price / Sales0.01177.05553.00121.74Price / CashN/A27.0925.7029.11Price / Book0.014.5912.176.09Net Income-$25.49M$189.47M$3.29B$266.19M7 Day PerformanceN/A0.25%1.13%0.44%1 Month PerformanceN/A8.34%8.30%4.88%1 Year PerformanceN/A18.21%71.05%26.03% Ontrak Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OTRKOntrak1.8159 of 5 stars$0.02-50.0%$3.00+14,900.0%-99.4%$84K$10.18M0.00250BACKIMACN/A$0.07+4.7%N/A-95.7%$152K$72.05K0.00180Positive NewsBTTXBetter TherapeuticsN/A$0.00flatN/AN/A$5KN/A0.0040UPHLUpHealthN/A$0.00flatN/A-99.9%$4K$130M0.001,750OPGNOpGenN/AN/AN/AN/A$1K$2.67M0.00100Short Interest ↓ACONWAclarionN/A$0.04+12.4%N/AN/A$0.00$62.95K0.007Positive NewsGap UpAONCAmerican Oncology NetworkN/A$10.71-3.9%N/A+266.7%$0.00$1.34B0.001,520Short Interest ↑High Trading VolumeDHACWDigital Health AcquisitionN/A$0.02-36.1%N/AN/A$0.00N/A0.00N/AGap DownHigh Trading VolumeFMSFresenius Medical Care AG & Co. KGaA3.9778 of 5 stars$25.71+2.3%$27.80+8.1%+25.7%$0.00$20.63B21.081,384News CoverageAnalyst DowngradeLFMDPLifeMDN/A$22.95-3.4%N/A+10.3%$0.00$245.56M0.00230Positive NewsGap DownOTRKPOntrakN/A$0.02-5.7%N/A-84.5%$0.00$10.84M0.00250Gap DownHigh Trading Volume Related Companies and Tools Related Companies BACK Competitors BTTX Competitors UPHL Competitors OPGN Competitors ACONW Competitors AONC Competitors DHACW Competitors FMS Competitors LFMDP Competitors OTRKP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OTRK) was last updated on 9/8/2025 by MarketBeat.com Staff From Our PartnersThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ontrak, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ontrak With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
